V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003655 | 10002314 | null | 86 | Adjuvant (A) | 2015-11-18 | 2015-12-02 | Capecitabine + Cisplatin | N | N | 10485295 | CAPECITABINE + GEMCITABINE |
| 10003656 | 10002315 | 1.62 | 91 | Disease modification (D) | 2016-08-30 | 2016-09-20 | CTD Attenuated (Thalidomide 50mg) | N | N | 10485354 | FLUOROURACIL + MITOMYCIN + RT |
| 10003657 | 10002316 | 1.66 | 78.9 | Disease modification (D) | 2018-11-05 | 2018-11-09 | Bortezomib + Cyclophos + Dex | 02 | N | 10485395 | CAPECITABINE + CISPLATIN |
| 10003658 | 10002316 | 0 | 65 | Disease modification (D) | 2014-09-23 | 2014-09-29 | Gemcitabine + Capecitabine | 2 | N | 10485395 | FLUOROURACIL + MITOMYCIN + RT |
| 10003659 | 10002317 | 1.64 | null | Disease modification (D) | 2017-02-03 | 2017-02-03 | EC | N | N | 10485484 | TEMOZOLOMIDE + RT |
| 10003660 | 10002318 | 1.64 | 55 | Palliative (P) | 2016-10-25 | 2016-11-02 | Capecitabine + Cisplatin | 02 | N | 10485486 | ABVD |
| 10003661 | 10002318 | 1.66 | 85 | Adjuvant (A) | 2015-07-07 | 2015-07-07 | FLUOROURACIL | N | N | 10485486 | FLUOROURACIL |
| 10003662 | 10002318 | 1.75 | 0 | Curative (C) | 2018-06-04 | 2018-06-11 | CISPLATIN + RT | 02 | N | 10485486 | CISPLATIN + RT |
| 10003663 | 10008812 | 1.7 | 73.1 | Palliative (P) | null | 2018-10-25 | Bortezomib + Cyclophos + Dex | N | N | 10485556 | CAPECITABINE + CISPLATIN |
| 10003664 | 10002319 | 1.88 | 77.5 | Curative (C) | 2016-09-27 | 2016-10-02 | Bortezomib +/- Dexamethasone | null | N | 10485581 | BORTEZOMIB |
| 10003665 | 10006477 | 1.66 | 81.6 | null | 2015-12-27 | 2016-01-14 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 10485605 | PACLITAXEL |
| 10003666 | 10002320 | 1.86 | 82.4 | Curative (C) | 2017-01-05 | 2017-01-12 | Capecitabine 35days + RT | N | Y | 10485642 | CAPECITABINE + RT |
| 10003667 | 10002321 | 1.59 | 63.1 | Palliative (P) | 2017-06-08 | 2017-06-08 | Cisplatin | 02 | N | 10485655 | CVD |
| 10003668 | 10002322 | 1.51 | null | Curative (C) | 2019-01-22 | 2019-02-05 | Capecitabine 42days + RT | 2 | Y | 10485656 | CAPECITABINE + RT |
| 10003669 | 10002323 | 1.65 | 87.4 | Curative (C) | 2017-03-08 | 2017-04-12 | CHOP | N | N | 10485667 | PACLITAXEL |
| 10003670 | 10002324 | 1.62 | 88.8 | Palliative (P) | null | 2018-05-21 | Irinotecan + Modified De Gramont | 99 | N | 10485727 | IRINOTECAN + MDG |
| 10003671 | 10002325 | 1.6 | 93 | Palliative (P) | 2018-05-17 | 2018-05-23 | Irinotecan + Modified De Gramont | 02 | N | 10485754 | IRINOTECAN + MDG |
| 10003672 | 10006478 | 1.76 | 80.8 | Curative (C) | 2015-09-30 | 2016-05-04 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10485847 | PACLITAXEL |
| 10003673 | 10006478 | 1.66 | 64 | Adjuvant (A) | 2017-02-06 | 2017-02-07 | FLUOROURACIL + IRINOTECAN | N | N | 10485847 | IRINOTECAN + MDG |
| 10003674 | 10002326 | 1.77 | null | Palliative (P) | null | 2015-11-23 | Irinotecan + Modified De Gramont | N | N | 10485872 | IRINOTECAN + MDG |
| 10003675 | 10002327 | 1.59 | 83.6 | Curative (C) | 2018-03-13 | 2018-03-19 | CAPECITABINE + RT | N | Y | 10485967 | CAPECITABINE + RT |
| 10003676 | 10002328 | 1.79 | 59.8 | Curative (C) | 2017-02-27 | 2017-03-13 | ABVD | 2 | N | 10485989 | CISPLATIN + ETOPOSIDE |
| 10003677 | 10002328 | 1.67 | null | Curative (C) | 2017-08-21 | 2017-08-22 | Temozolomide + RT | null | N | 10485989 | CVD |
| 10003678 | 10002329 | 1.67 | null | Curative (C) | 2016-02-17 | 2016-02-17 | Cisplatin 100 + RT(H&N) 1 day | N | N | 10486022 | CISPLATIN + RT |
| 10003679 | 10002330 | 1.62 | null | Adjuvant (A) | 2017-01-24 | 2017-02-07 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10486032 | ABVD |
| 10003680 | 10002330 | 1.55 | 69 | null | 2016-07-03 | 2016-07-03 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10486032 | FLUOROURACIL + MITOMYCIN + RT |
| 10003681 | 10002330 | 0 | 71.2 | Adjuvant (A) | 2016-04-14 | 2016-04-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10486032 | ABVD |
| 10003682 | 10002330 | 1.76 | 86 | Adjuvant (A) | 2017-12-23 | 2017-12-23 | CTD (Thalidomide 100mg) | 2 | N | 10486032 | IMATINIB |
| 10003683 | 10009105 | 1.66 | 102 | Adjuvant (A) | 2018-04-26 | 2018-05-24 | Abiraterone | N | Y | 10486160 | CVD |
| 10003684 | 10009105 | 1.56 | 52.6 | Adjuvant (A) | null | 2018-06-19 | CTD Attenuated (Thalidomide 50mg) | N | N | 10486160 | CHOP |
| 10003685 | 10009105 | 1.52 | 73 | Palliative (P) | 2014-07-04 | 2014-07-05 | Capecitabine + Cisplatin | 02 | N | 10486160 | ABVD |
| 10003686 | 10009297 | 1.72 | 56.5 | Curative (C) | 2015-09-09 | 2015-09-19 | Chlorambucil | N | N | 10486273 | CAPECITABINE + CISPLATIN |
| 10003687 | 10002331 | 1.53 | 62.2 | Palliative (P) | 2017-09-13 | 2017-09-15 | CTD | 2 | N | 10486287 | CVD |
| 10003688 | 10002332 | 1.77 | 69.4 | Disease modification (D) | 2018-05-21 | 2018-05-28 | Bortezomib +/- Dexamethasone | 02 | N | 10486306 | IMATINIB |
| 10003689 | 10002333 | 1.6 | 47 | Palliative (P) | 2017-11-20 | 2017-11-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10486311 | ABVD |
| 10003690 | 10002333 | 1.57 | 64.2 | Curative (C) | 2013-02-17 | 2013-03-16 | CAPECITABINE + RT | N | Y | 10486311 | CAPECITABINE + RT |
| 10003691 | 10002334 | 1.59 | 66.75 | Curative (C) | 2018-04-30 | 2018-04-30 | Bortezomib (weekly) | 2 | Y | 10486352 | ABIRATERONE |
| 10003692 | 10002335 | null | 91.1 | Neo-adjuvant (N) | 2018-09-27 | 2018-10-18 | FEC + DOCETAXEL | 02 | N | 10486367 | FEC + DOCETAXEL |
| 10003693 | 10006482 | 1.76 | 101 | Disease modification (D) | 2015-02-24 | 2015-02-24 | Capecitabine + Cisplatin | 02 | N | 10486380 | BORTEZOMIB |
| 10003694 | 10002336 | null | 77.5 | Curative (C) | 2012-12-30 | 2018-02-17 | EC | 2 | N | 10486401 | ABIRATERONE |
| 10003695 | 10002336 | 1.73 | 83 | Palliative (P) | null | 2017-11-08 | CHOP - 21 days | N | N | 10486401 | ABIRATERONE |
| 10003696 | 10002337 | 1.63 | 86 | Curative (C) | 2017-05-05 | 2017-05-05 | Bortezomib +/- Dexamethasone | 2 | N | 10486537 | CISPLATIN + ETOPOSIDE |
| 10003697 | 10002337 | 1.68 | 90.6 | Palliative (P) | 2017-09-12 | 2017-10-02 | Chlorambucil | N | N | 10486537 | ABIRATERONE |
| 10003698 | 10002338 | 1.69 | null | Adjuvant (A) | 2018-11-28 | 2018-11-29 | FEC 100 + DOCETAXEL | N | N | 10486546 | FEC + DOCETAXEL |
| 10003699 | 10002339 | 1.6 | 81.3 | Curative (C) | 2016-03-29 | 2016-05-02 | Capecitabine 35days + RT | 99 | Y | 10486606 | CAPECITABINE + RT |
| 10003700 | 10002339 | null | 66.8 | Palliative (P) | 2018-05-22 | 2018-06-14 | Chlorambucil | N | N | 10486606 | CHOP |
| 10003701 | 10002340 | 1.55 | null | Adjuvant (A) | 2019-02-13 | 2019-02-25 | FEC + DOCETAXEL | N | N | 10486704 | FEC + DOCETAXEL |
| 10003702 | 10002340 | null | 86.8 | Palliative (P) | null | 2017-03-04 | FLUOROURACIL | 99 | N | 10486704 | FLUOROURACIL |
| 10003703 | 10002341 | 1.8 | 90.4 | Adjuvant (A) | 2014-02-23 | 2014-03-19 | Abiraterone | N | Y | 10486759 | EC |
| 10003704 | 10002342 | 1.65 | 72 | Disease modification (D) | 2015-02-18 | 2015-02-18 | Bortezomib + Cyclophos + Dex | N | N | 10486776 | ABVD |